Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,116Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Acme Lifetech

02 1Aeron Remedies

03 4Aurobindo Pharma Limited

04 2Caristar Laboratories

05 2Delius Pharmaceuticals

06 2Dycine Pharma

07 1Halewood Laboratories Pvt. Ltd

08 1Hanlim Pharmaceuticals Inc

09 3LAB.GUIDOTTI SpA

10 1Myungmoon Pharm. Co., LTD.

11 5PTC Therapeutics

12 4Sun Pharmaceutical Industries Limited

13 2Swasthya Healthcare

14 3TEOFARMA Srl

15 1Tris Pharma Inc

16 1Unicor Pharmatech

17 4Upsher-Smith Laboratories

18 1Vaishali Pharma Ltd

19 1Vega Biotech Pvt. Ltd.

20 5ZRS LABS

21 1Zota Healthcare Ltd

22 4Zydus Lifesciences

23 26Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-02-09

Application Number : 217123

Regulatory Info : RX

Registration Country : USA

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2017-02-09

Application Number : 208684

Regulatory Info : RX

Registration Country : USA

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : EMFLAZA

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2017-02-09

Application Number : 208685

Regulatory Info : RX

Registration Country : USA

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

11

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

12

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

13

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2025-03-18

Application Number : 217741

Regulatory Info : RX

Registration Country : USA

blank

14

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 22.75MG/ML

Packaging :

Approval Date : 2024-04-25

Application Number : 217813

Regulatory Info : RX

Registration Country : USA

blank

15

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

16

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

17

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

18

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : DEFLAZACORT

Dosage Form : TABLET;ORAL

Dosage Strength : 36MG

Packaging :

Approval Date : 2024-11-05

Application Number : 216720

Regulatory Info : RX

Registration Country : USA

blank

19

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : JAYTHARI

Dosage Form : TABLET;ORAL

Dosage Strength : 6MG

Packaging :

Approval Date : 2025-04-08

Application Number : 219254

Regulatory Info : RX

Registration Country : USA

blank

20

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

DEFLAZACORT

Brand Name : JAYTHARI

Dosage Form : TABLET;ORAL

Dosage Strength : 18MG

Packaging :

Approval Date : 2025-04-08

Application Number : 219254

Regulatory Info : RX

Registration Country : USA

blank